BioMarin Pharmaceutical Inc. (BMRN)
$54.80-0.16%Close
SELLBEAR · day 24
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $10.6B
- Beta
- 0.24
- P/E (TTM)
- 147.95
- Short % float
- 6.00%
- Days to cover
- 5.5
- SI change
- +14.4%
- 1W
- -4.16%
- 1M
- -16.35%
- vs SPY 1W
- -5.32%
- vs SPY 1M
- -19.34%
Industry peers
FMP comparable companies · ranked by market cap
- VRTXSELLVertex Pharmaceuticals Incorporated$127.7BBEARQ 23$503.25+1.36%
- ALNYSELLAlnylam Pharmaceuticals, Inc.$30.0BRECOVERYQ 28$224.53+3.63%
- INSMSELLInsmed Incorporated$21.8BCRISISQ 13$100.48+0.12%
- ASNDSELLAscendis Pharma A/S$13.8BRECOVERYQ 35$222.69+2.94%
- BBIOSELLBridgeBio Pharma, Inc.$12.7BRECOVERYQ 18$65.04+0.48%
- IONSSELLIonis Pharmaceuticals, Inc.$7.2BRECOVERYQ 8$43.30+4.57%
- PTCTSELLPTC Therapeutics, Inc.$5.2BRECOVERYQ 18$62.56+3.42%
- TVTXSELLTravere Therapeutics, Inc.$4.8BCRISISQ 33$52.04+0.17%
- RAREBUYUltragenyx Pharmaceutical Inc.$1.5BRECOVERYQ -6$15.29+1.24%
- PHARSELLPharming Group N.V.$675MCRISISQ -1$9.53+2.73%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on BMRN?
- LOPJLB’s latest quantitative signal on BioMarin Pharmaceutical Inc. (BMRN) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is BMRN in?
- BioMarin Pharmaceutical Inc. (BMRN) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does BioMarin Pharmaceutical Inc. (BMRN) do?
- BioMarin Pharmaceutical Inc. specializes in creating and bringing to market treatments for individuals suffering from severe and often fatal rare disorders and other critical medical conditions. The company currently markets several key pharmaceutical products. Among these are Vimizim, an enzyme replacement therapy targeting mucopolysaccharidosis (MPS) IV type A, a specific lysosomal storage di…